Yes

Antispasmodic Agent, Gastrointestinal

Adjunct treatment of peptic ulcer; treatment of irritable bowel syndrome

D

Glaucoma; prostatic hypertrophy; benign bladder neck obstruction; hypersensitivity to clidinium, chlordiazepoxide, or any component

Use with caution with alcohol or other CNS depressants because of possible combined effects. Do not abruptly discontinue this medication after prolonged use; taper dose gradually.

1% to 10%: Drowsiness ataxia, confusion, anticholinergic side effects

Additive effects may result from concomitant benzodiazepine and/or anticholinergic therapy

Oral: 1-2 capsules 3-4 times/day, before meals or food and at bedtime

Should be administered before meals

Drowsiness is common; may cause confusion

Concurrent use with psychotropics may result in additive sedation

No information available to require special precautions

No effects or complications reported

Take as directed before meals; do not increase dose and do not discontinue without consulting prescriber first. Avoid alcohol and other CNS depressant medications (antihistamines, sleeping aids, antidepressants) unless approved by prescriber. Void before taking medication. This drug may impair mental alertness (use caution when driving or engaging in tasks that require alertness until response to drug is known). Report excessive and persistent anticholinergic effects (blurred vision, headache, flushing, tachycardia, nervousness, constipation, dizziness, insomnia, mental confusion or excitement, dry mouth, altered taste perception, dysphagia, palpitations, bradycardia, urinary hesitancy or retention, impotence, decreased sweating), or change in color of urine or stools. Pregnancy/breast-feeding precautions: Do not get pregnant while taking this medication; use appropriate barrier contraceptive measures. Do not breast-feed.

After extended therapy, abrupt discontinuation should be avoided and a gradual dose tapering schedule followed

Capsule: Clidinium bromide 2.5 mg and chlordiazepoxide hydrochloride 5 mg